but are as corrupt(ible) as any past generation...the corrupt seek power...management offers power...
...management left to its own devices tends to pursue (its own) main chance imv
yep...why bother with this?
..wig was funny (and lucky/right)
...but it's all about management ...and this is right up there (in the wrong way)...against stiff AIMster competition
...Mrs T raved about management..AIM shows that she was dead wrong...management is usually dreadful...and that is why strong ownership oversight is so vital
enjoy the ascent
...£10 is easy target if investors buy into steady growth a la tfw/rbn
..happy days, weeks, years, decades
..if jolly made shares, they would be dwha
then 25-7p may be easy.....and much higher in 2016 if momentum in expanded business maintained
...wot a buy @6p lol (other than impossible to quantify israeli/audit/fraud risk...and majority control, wot not to like??)
yes...he has had poor 2015 wrt tiddlers (as far as i have seen)...he always liked pharma, but biotech is different
...i am eyeing up distress levels here, sng, sphr for cheeky pays early / mid 16
..merry xmas
good work
...traded a fair few lads...still hold a rump free carry here...but much better value elsewhere (look at my recent postings if interested)
..merry xmas, all